Next Issue
Volume 173, 08
Previous Issue
Volume 173, 04
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
SANPP
Volume 173
Issue 3
share announcement
Swiss Archives of Neurology, Psychiatry and Psychotherapy is published by MDPI from Volume 176 Issue 1 (2026). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the previous journal publisher.

Swiss Arch. Neurol. Psychiatry Psychother., Volume 173, Issue 3 (06 2022) – 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
2324 KB  
Book Review
Jörg Singer (Herausgeber): Hans Kunz. Schriften zur Psychoanalyse II. Frühe Beiträge zur Psychoanalyse (1928–1940) und ausgewählte Rezensionen zur psychoanalytischen Literatur
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 92-93; https://doi.org/10.4414/sanp.2022.w10020 - 16 Jun 2022
Viewed by 34
Abstract
In einer früheren Rezension zu Band 8 der Gesammelten Schriften habe ich kurze Hinweise auf Leben und Werk von Hans Kunz gegeben, die ich nicht wiederholen werde [...] Full article
2226 KB  
Article
Clothiapine: highlights of the pharmacological and clinical profile of an undervalued drug
by Calogero Crapanzano, Chiara Amendola, Claudia Conigliaro and Ilaria Casolaro
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 71-74; https://doi.org/10.4414/sanp.2022.w10065 - 16 Jun 2022
Viewed by 52
Abstract
Clothiapine is a quite widely used, but understudied, first-generation antipsychotic with the pharmacodynamic properties of aliphatic phenothiazines and clozapine. The aim of our comprehensive review was to summarise state of the art clinical and pharmacological data concerning the use of clothiapine in several [...] Read more.
Clothiapine is a quite widely used, but understudied, first-generation antipsychotic with the pharmacodynamic properties of aliphatic phenothiazines and clozapine. The aim of our comprehensive review was to summarise state of the art clinical and pharmacological data concerning the use of clothiapine in several psychiatric conditions. The main evidence is from shortterm studies evaluating efficacy in schizophrenia versus active comparators. Off-label use in alcohol abstinence and insomnia is also reported with preliminary promising findings. Few studies systematically investigated the tolerability and safety of clothiapine, specifically extrapyramidal symptoms and its effect on the QT interval, which appear comparable to other first-generation antipsychotics. From the scientific literature, we believe that this drug has not been adequately investigated and consequently it risks being a valid, but underutilised, pharmacological tool in psychiatry. Full article
855 KB  
Article
«Meine Jacke» von Agnes Emma Richter
by Sollberger Daniel
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 1-2; https://doi.org/10.4414/sanp.2022.w10104 - 16 Jun 2022
Abstract
Wie in einem früheren Text anhand der Arbeiten von Emma Hauck beschrieben [...] Full article
►▼ Show Figures

Figure 1

648 KB  
Article
Le trouble dépressif dans le film Melancholia
by Mahaut Pache, Paul Semboglou, Louise Penzenstadler and Gerard Calzada
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 1-4; https://doi.org/10.4414/sanp.2022.w10102 - 16 Jun 2022
Abstract
Ce film présente l’attitude d’une personne souffrant d’un trouble dépressif vis-à-vis de sa famille, ainsi que de sa propre mort, dans un contexte de fin du monde [...] Full article
2308 KB  
Article
Es ist eine Herkulesaufgabe, das Image der Psychiatrie zu verbessern
by Fulvia Rota and Karl Studer
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 94-95; https://doi.org/10.4414/sanp.2022.w10096 - 15 Jun 2022
Viewed by 34
Abstract
Interview mit Frau Dr. med. Fulvia Rota, Präsidentin der Schweizerischen Gesellschaft für Psychiatrie und Psychotherapie (SGPP) [...] Full article
2324 KB  
Book Review
Elisabeth Drimalla: Sexuelle Funktionsstörungen. Ein Leitfaden für die Psychotherapie und ärztliche Praxis
by EMH Swiss Medical Publishers Ltd.
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 93; https://doi.org/10.4414/sanp.2022.w10087 (registering DOI) - 15 Jun 2022
Viewed by 36
Abstract
Dieses Buch ist für alle lesenswert, die sich mit dem aktuellen Wissensstand in der Behandlung sexueller Funktionsstörungen befassen wollen. Es eignet sich für praktisch Tätige, Hausärzt*innen, Psychiater*innen und Psychotherapeut*innen. Die Gliederung ist klar und übersichtlich [...] Full article
2329 KB  
Article
Correlates of full adherence to integrated treatment in early psychosis
by Philippe Golay, Dina Ezzat and Philippe Conus
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 82-83; https://doi.org/10.4414/sanp.2022.w10098 - 15 Jun 2022
Viewed by 36
Abstract
To the best of our knowledge, this is the first study to explore adherence to the combination of various recommended elements of specialised early psychosis programmes. This is astonishing, since all recommendations in this domain stress the importance, along with adapted medication, of [...] Read more.
To the best of our knowledge, this is the first study to explore adherence to the combination of various recommended elements of specialised early psychosis programmes. This is astonishing, since all recommendations in this domain stress the importance, along with adapted medication, of other treatment components such as case management, psychosocial intervention, family intervention and supported employment. Various interesting elements stem from our data analysis. First, the vast majority of patients reach adherence to all elements of treatment at some point of the 3-year programme we propose. Second, lack of development of insight and persistence of substance abuse are the strongest correlates of failure to adhere to integrated treatment, along with the presence of a forensic history. Third, patients who fail to fully adhere to integrated treatment have poorer symptomatic remission and poorer insight after the entire treatment period. Finally, although some patients who never fully adhered to treatment over the entire 3 years reached a reasonable level of functioning, the vast majority did not and only 8% of them returned to independent work combined with independent living. Based on these results, it seems clear that promoting adherence to all the elements of specialised integrated treatment should be an aim with early psychosis patients. Full article
2155 KB  
Article
Age at the onset of a first episode of psychotic mania is not a determinant of short-term outcome in a specialised early psychosis treatment setting
by Philippe Conus, Martin Lambert and Sue M. Cotton
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 76-77; https://doi.org/10.4414/sanp.2022.w10077 - 15 Jun 2022
Viewed by 57
Abstract
Numerous publications have shown that the outcome of bipolar disorder is worse than previously thought, with poor outcomes evident from the first episode of mania. Although the manic syndrome usually resolves rapidly in the vast majority of patients, functional outcome often lags behind. [...] Read more.
Numerous publications have shown that the outcome of bipolar disorder is worse than previously thought, with poor outcomes evident from the first episode of mania. Although the manic syndrome usually resolves rapidly in the vast majority of patients, functional outcome often lags behind. In this context, it is important to study the outcome of mania in various settings and to identify predictors of outcome in order to identify sub-groups of patients with specific needs. In this study, we explored the outcome of 118 patients with a first episode of psychotic mania (FEPM) treated at EPPIC, Melbourne, Australia, and, more specifically, the impact of age at onset (<21 years and ≥21 years) of this first episode on 18-month outcome. Globally, patients had a good level of premorbid functioning in spite of high rates of exposure to sexual and physical abuse and of cannabis use. After presenting with very intense symptoms and low functioning at entry to the service, outcome was rather good, which suggests that adequate treatment provided in a specialised setting allows a favourable outcome after FEPM. The good quality of this treatment may explain why we did not find any difference in outcome when comparing subgroups defined by age at onset of FEPM. Full article
2037 KB  
Editorial
Neurologie, Psychiatrie und Kognition
by Hennric Jokeit
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 69-70; https://doi.org/10.4414/sanp.2022.w10106 (registering DOI) - 15 Jun 2022
Viewed by 33
Abstract
Der moderne Kapitalismus wird kognitiv genannt, weil seine Wertschöpfung wesentlich auf den kognitiven Leistungen menschlicher Arbeitskraft beruht [1,2]. Full article
2180 KB  
Case Report
Le démarrage
by Logos Curtis, Silke Bachmann and Daniele Zullino
Swiss Arch. Neurol. Psychiatry Psychother. 2022, 173(3), 90-91; https://doi.org/10.4414/sanp.2022.w10105 - 1 May 2022
Viewed by 31
Abstract
En pleine crise sanitaire, due à la pandémie du Covid-19, Monsieur Fréderic Levert, un jeune homme de19 ans, vient de débuter ses études de médecine [...] Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-10
Previous Issue
Next Issue
Back to TopTop